Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Sleep Aids market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
The Sleep Aids market in Norway has been experiencing steady growth in recent years, driven by changing customer preferences and an increasing awareness of the importance of sleep for overall health and well-being.
Customer preferences: In Norway, there is a growing demand for sleep aids that are natural and non-habit forming. Customers are increasingly seeking out products that contain herbal ingredients or are made from organic materials. This preference for natural sleep aids can be attributed to a general trend towards healthier and more sustainable lifestyles in the country.
Trends in the market: One of the key trends in the Sleep Aids market in Norway is the rising popularity of sleep tracking devices and apps. These technologies allow individuals to monitor their sleep patterns and identify areas for improvement. As a result, there is a growing demand for sleep aids that can complement these technologies, such as aromatherapy products or relaxation techniques.Another trend in the market is the increasing availability of sleep aids in different formats. In addition to traditional pills and capsules, there is a growing range of sleep aids available in the form of sprays, patches, and even beverages. This variety of formats allows customers to choose the option that best suits their preferences and lifestyle.
Local special circumstances: Norway has a high standard of living and a well-developed healthcare system, which has contributed to the growth of the Sleep Aids market. The country has a high level of disposable income, allowing individuals to invest in products that can improve their sleep quality. Additionally, the healthcare system in Norway places a strong emphasis on preventive care, including sleep health, which has further contributed to the demand for sleep aids.
Underlying macroeconomic factors: The growth of the Sleep Aids market in Norway can also be attributed to several underlying macroeconomic factors. The country has a high level of employment and a stable economy, which has resulted in increased consumer spending power. Additionally, Norway has a rapidly aging population, which has led to a greater focus on health and wellness products, including sleep aids.In conclusion, the Sleep Aids market in Norway is experiencing growth due to changing customer preferences, including a preference for natural and non-habit forming sleep aids, as well as an increasing awareness of the importance of sleep for overall health. The market is also influenced by trends such as the popularity of sleep tracking devices and the availability of sleep aids in different formats. Additionally, the high standard of living and well-developed healthcare system in Norway, along with underlying macroeconomic factors, contribute to the growth of the market.
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights